Rheumatoid Arthritis Treatment Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00 – $ 8,900.00

Rheumatoid Arthritis Treatment Market By Drugs Type (Non-Steroidal anti-inflammatory Drugs (NSAIDs), Corticosteroids, Disease modifying anti-rheumatic drugs (DMARDs)), By Treatment (Synovectomy, Tendon Repair, Joint Fusion), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Healthcare, Pharmaceuticals

Description
Table Of Content
Company Profile

Report

Description

Rheumatoid Arthritis Treatment Market size was valued at USD 22.9 billion in 2021, growing at a CAGR of 4.6% from 2022-28. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global rheumatoid arthritis treatment products. The World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of worldwide significance on January 30, 2020. Around 210 countries have been affected by COVID-19. Patients with rheumatoid arthritis who contract COVID-19 infection, according to the Lancet Rheumatology 2020, are at a high risk of developing severe symptoms and further consequences.Many DMARDs are in wide adoption as a first-line treatment for rheumatoid arthritis, such as sulphasalazine, methotrexate and hydroxychloroquine. Major companies like Can-Fite BioPharma Ltd. are investigating several novel antirheumatic disease modifying agents that are expected to be available in the market in the next 10 years, uptake of which by prescribers and patients would push market growth.

Rheumatoid Arthritis Treatment Market

MARKET SUMMARY

4.6%

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 4.6%
Largest Market– North America
Fastest Growing Market– Asia Pacific

Rheumatoid Arthritis Treatment Market Analysis

Rheumatoid arthritis treatment market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
The report gives historical, current, and future market sizes (US$ Mn) on the basis of drugs type, treatment type, end user, and region.

Market Leaders

AbbVie Inc.
Johnson & Johnson Services
Amgen Inc.
Pfizer
Cadila Healthcare Ltd.
Novartis AG.
AstraZeneca
Hoffman-La Roche Ltd
Bristol-Myers Squibb Company
GlaxoSmithKline

Rheumatoid Arthritis Treatment Market

Drivers and Restraints

owing introduction of newer therapies into the market and availability of FDA approved biologic drugs such as rituximab, abatacept, etanercept, etc. are expected to fuel consumption of rheumatoid arthritis treatment market. Moreover, emerging economies are highly adopting towards novel technologies and therapies and increase in disposable income and products that are ready to get approval from FDA for the treatment of rheumatoid arthritis expected to propel the growth of the market. However, high costs associated with biological DMARD therapies may hinder the growth of the market over future years.Conventional DMARDs is the most common therapy for Rheumatoid Arthritis. These drugs are available in different dosage forms including oral as well as parenteral, each dosage form having a different treatment regime. Biological DMARD includes biologic agents that are approved for the treatment of rheumatoid arthritis. Any biologic treatment that is not approved by the regulatory authorities or is under investigation is beyond the scope of this report.

Rheumatoid Arthritis Treatment Market

North America dominates the market

North America accounted for larger revenue share in global rheumatoid arthritis treatment market with significant CAGR owing to factors increasing prevalence of disorders related with rheumatoid arthritis and large number of rheumatoid arthritis patient. Europe has shown significant growth in last few decades in rheumatoid arthritis treatment market. Asia pacific will grow at highest CAGR over the forecast period in rheumatoid arthritis treatment market owing to factors like increasing healthcare expenditure, rising obese population, and increasing cigarette consumption in the region. Middle East & Africa will grow at moderate rate in rheumatoid arthritis treatment market owing to factor the treatment cost is high for the disease.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Rheumatoid Arthritis Treatment Market Segmentation

Drugs Type

Non-Steroidal anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Disease modifying anti-rheumatic drugs (DMARDs)
- Conventional DMARD
- Biologic DMARD

Treatment Type

Synovectomy
Tendon Repair
Joint Fusion

End User

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers

Geography

North America
Latin America
Europe
Asia Pacific
Middle East and africa

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

Table of Contents

Executive Summary
Global Rheumatoid Arthritis Treatment Market Introduction
- Global Rheumatoid Arthritis Treatment Market – Taxonomy
- Global Rheumatoid Arthritis Treatment Market –Definitions
  - By Drugs Type
  - By Treatment Type
  - By End User

Global Rheumatoid Arthritis Treatment Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Rheumatoid Arthritis Treatment Market Dynamics – Factors Impact Analysis
Global Rheumatoid Arthritis Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
- Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%)
- Market Opportunity Analysis
Global Rheumatoid Arthritis Treatment Market Forecast, By Drugs Type, 2014 – 2018 and Forecast, 2019 – 2025
- Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Corticosteroids
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Disease modifying anti-rheumatic drugs (DMARDs)
  - Conventional DMARD
    - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    - Market Opportunity Analysis
  - Biologic DMARD
    - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    - Market Opportunity Analysis

Global Rheumatoid Arthritis Treatment Market Forecast, By Treatment, 2014 – 2018 and Forecast, 2019 – 2025
- Synovectomy
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Tendon Repair
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Joint Fusion
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Rheumatoid Arthritis Treatment Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
- Hospitals
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Diagnostic Centers
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Ambulatory Surgical Centers
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Rheumatoid Arthritis Treatment Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025
- North America
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Europe
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Asia Pacific
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Latin America
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- The Middle East & Africa
  - Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Global Rheumatoid Arthritis Treatment Market – Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Region, 2019 – 2025
North America Rheumatoid Arthritis Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
- Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  - Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Disease modifying anti-rheumatic drugs (DMARDs)
    - Conventional DMARD
    - Biologic DMARD
  - Treatment Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Synovectomy
    - Tendon Repair
    - Joint Fusion
  - End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Hospitals
    - Diagnostic Centers
    - Ambulatory Surgical Centers
  - Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    - US
    - Canada
  - North America Rheumatoid Arthritis Treatment Market – Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2019 – 2025
  - North America Rheumatoid Arthritis Treatment Market Dynamics – Trends

Europe Rheumatoid Arthritis Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
- Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  - Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Disease modifying anti-rheumatic drugs (DMARDs)
    - Conventional DMARD
    - Biologic DMARD
  - Treatment Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Synovectomy
    - Tendon Repair
    - Joint Fusion
  - End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Hospitals
    - Diagnostic Centers
    - Ambulatory Surgical Centers
  - Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    - UK
    - Germany
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
  - Europe Rheumatoid Arthritis Treatment Market – Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2019 – 2025
  - Europe Rheumatoid Arthritis Treatment Market Dynamics – Trends

Asia Pacific Rheumatoid Arthritis Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
- Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  - Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Disease modifying anti-rheumatic drugs (DMARDs)
    - Conventional DMARD
    - Biologic DMARD
  - Treatment Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Synovectomy
    - Tendon Repair
    - Joint Fusion
  - End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Hospitals
    - Diagnostic Centers
    - Ambulatory Surgical Centers
  - Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    - China
    - Japan
    - India
    - ASEAN Counties
    - Philippines
    - Rest of Asia Pacific
  - Asia Pacific Rheumatoid Arthritis Treatment Market – Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2019 – 2025
  - Asia Pacific Rheumatoid Arthritis Treatment Market Dynamics – Trends

Latin America Rheumatoid Arthritis Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
- Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  - Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Disease modifying anti-rheumatic drugs (DMARDs)
    - Conventional DMARD
    - Biologic DMARD
  - Treatment Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Synovectomy
    - Tendon Repair
    - Joint Fusion
  - End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Hospitals
    - Diagnostic Centers
    - Ambulatory Surgical Centers
  - Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    - Mexico
    - Brazil
    - Argentina
    - Chile
    - Rest of Latin America
  - Latin America Rheumatoid Arthritis Treatment Market – Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2019 – 2025
  - Latin America Rheumatoid Arthritis Treatment Market Dynamics – Trends

Middle East and Africa Rheumatoid Arthritis Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
- Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  - Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Disease modifying anti-rheumatic drugs (DMARDs)
    - Conventional DMARD
    - Biologic DMARD
  - Treatment Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Synovectomy
    - Tendon Repair
    - Joint Fusion
  - End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    - Hospitals
    - Diagnostic Centers
    - Ambulatory Surgical Centers
  - Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    - GCC Countries
    - South Africa
    - Saudi Arabia
    - Turkey
    - Rest of MEA
  - Middle East and Africa Rheumatoid Arthritis Treatment Market – Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2019 – 2025
  - Middle East and Africa Rheumatoid Arthritis Treatment Market Dynamics – Trends

Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
  - AbbVie Inc.
  - Johnson & Johnson Services
  - Amgen Inc.
  - Pfizer
  - Cadila Healthcare Ltd.
  - Novartis AG.
  - AstraZeneca
  - Hoffman-La Roche Ltd
  - Bristol-Myers Squibb Company
  - GlaxoSmithKline
Research Methodology
Key Assumptions and Acronyms

Description

search

Rheumatoid Arthritis Treatment Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

Description

Rheumatoid Arthritis Treatment Market Analysis

Drivers and Restraints

North America dominates the market

Features of the Report

Drugs Type

Treatment Type

End User

Geography

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE